Cedars-Sinai Launches Customized, Convenient Virtual Second Opinion Throughout California and Several Additional States

Cedars-Sinai is taking telehealth and the patient experience to the next level, now offering Cedars-Sinai Virtual Second Opinion—an online platform connecting individuals in need of complex cardiac, spine or gynecologic care with top-ranked experts who provide customized treatment options and virtual education sessions.

January Research Highlights

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Mediterranean Diet Linked to Lower Preeclampsia Risk

In a new study evaluating the Mediterranean diet and adverse pregnancy outcomes, investigators from the Smidt Heart Institute at Cedars-Sinai found that women who conceived while adhering to the anti-inflammatory diet had a significantly lower risk of developing preeclampsia during pregnancy.

Cardiothoracic Surgeon to Lead Smidt Heart Institute’s ECMO Program

The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler Gunn, MD, to be the director of the Extracorporeal Membrane Oxygenation, or ECMO, Program in the Department of Cardiac Surgery.

Cedars-Sinai Awarded $8 Million to Launch New Stem Cell Clinic

Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.

Q&A With Vascular Surgeon Elizabeth Chou, MD

After 11 years spent in medical school, residency and fellowships, Elizabeth Chou, MD, a vascular surgeon who recently joined the Smidt Heart Institute at Cedars-Sinai, has earned her dream career. And she has no plans of stopping there. She’s on a path toward ensuring women in vascular surgery are represented—as incoming physicians and as patients.

When Catastrophe Strikes, ‘Think Aorta’

Vascular and cardiac surgeons in the Smidt Heart Institute at Cedars-Sinai know all too well the danger that looms when a patient experiences a tear in their heart’s main artery, called an aortic dissection. The condition, however, is often mistaken by patients—and even some physicians and nurses—for a heart attack, which can delay diagnosis and subsequent lifesaving surgery.

Late-Breaking Heart Research: AI More Accurate Than Technicians

In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.

Genetic Score Detects Those at Risk for Sudden Cardiac Death

Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.

Smidt Heart Institute Experts to Present Innovative Research Findings at European Society of Cardiology Congress 2022

Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.

Cedars-Sinai Lung Transplant Outcomes Rated Outstanding

A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.

Hypertension Elevates Risk for More Severe COVID-19 Illness

Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai. The findings are published in the journal Hypertension.

A Lifetime of Heart Care Leads to Transplant

While many 21-year-olds celebrate their coming of age in bars and nightclubs, Andrew Solis is celebrating freedom by finally going home—equipped with a new heart and liver—after nearly eight months at Cedars-Sinai.

First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting

Investigators from Cedars-Sinai will present the latest novel stem cell and regenerative medicine research at the International Society for Stem Cell Research (ISSCR) Annual Meeting, which is being held in person and virtually June 15-19 in San Francisco.

National Leader in Cardiac Surgery Quality and Research Joins Cedars-Sinai

Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons continuously funded by the National Institutes of Health for a decade, has been appointed vice chair of the Department of Cardiac Surgery in the Smidt Heart Institute.

May Research Highlights

A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai

Smidt Heart Institute: Annual Report Highlights

The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.

Smidt Heart Institute Experts Featured at AHA Scientific Sessions 2021

Experts from the Smidt Heart Institute, home to California’s top cardiology and heart surgery program, will highlight an array of innovative research, clinical trial data and breakthrough topics during the American Heart Association Scientific Sessions 2021, taking place virtually Nov. 13-15.

Saving Lives in Black Barbershops

A new look at data from a landmark Cedars-Sinai study of health interventions in Black barbershops, and a new study that looks at barbershop patrons’ virtual visits with pharmacists, have added to the evidence that convenient, community-based health programs can cost-effectively control high blood pressure and prevent heart attack and stroke.

After 20-Year Search, ‘Undiagnosable’ Patient Gets Answer: POTS

Kim Ryberg, 33, remember the first time she fainted at age 13. Over the next two decades, Ryberg experienced life-altering symptoms like regular fainting spells, extreme vertigo and excessive hot and cold flashes. Her symptoms diminished her quality of life, leaving her Kim Ryberg unable to drive, work or have children with her husband, for fear of fainting and causing an accident. She sought answers from more than 50 doctors, but never received a diagnosis.

A Patient Pioneer: Minimally Invasive Lung Transplantation

To anyone else, it’s just a walk around the block. But for Frank Coburn, 57, and his wife, it’s a miracle. A miracle that resulted from Coburn becoming the first Southern Californian—and possibly first in the U.S.—to receive a minimally invasive double lung transplant. The procedure was performed at the Smidt Heart Institute.

#YearofCOVID: The Evolution of Care

Peter Chen, MD, remembers those early days of March 2020 as one of swirling hyperactivity in the intensive care unit he leads at Cedars-Sinai. Chen and his team were struggling to respond to an emerging health crisis that was quickly growing into a global pandemic.

COVID-19 Risk Factors for Healthcare Workers: Race, Ethnicity

Healthcare workers might not be so different from the general population in the factors that determine their risk of getting COVID-19. A new study led by Cedars-Sinai shows that healthcare workers are more likely to have antibodies to COVID-19 in their blood if they are African American or Latino or have hypertension.

Healthcare Innovation Eases Burden on ICU Staff

Throughout the COVID-19 crisis, Cedars-Sinai employees have stepped-up and stepped-in to support patients and colleagues alike. And while there has been no shortage of selflessness, one group of volunteers shines a bright light on both the innovation and teamwork spurring from the past 10 months of treating the sickest of patients.

Enhanced Oral Uptake of Exosomes Opens Cell Therapy Alternative

Cell-derived exosomes are effective in treating disease when mixed with the dominant protein in breast milk and given orally, a new Smidt Heart Institute study of laboratory mice shows. The findings, published in the peer-reviewed Journal of Extracellular Vesicles, could help develop new oral medications for treating patients with muscular dystrophy and heart failure.